Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+5.63%
+2.46%
+2.60%
INSM
Insmed
$65.71
Chart
73.44
83.83
69.95
53.55
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.63%
+2.46%
+2.60%
INSM
Insmed
$65.71
Chart
73.44
83.83
69.95
53.55
INSM Latest Headlines
This Insmed Analyst Begins Coverage On A ish Note. Here Are Top 5 Initiations For Tuesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.Jefferies analyst Kelly Shi initiated coverage on ) with a Buy rating and announced a price target of $105. Insmed shares closed at $67.75 on Monday. See how other analysts view this stock.BMO Capital analyst E
Today
Analyst Expectations For Insmeds Future. Insmed (NASDAQ:) underwent analysis by 13 analysts in the last quarter revealing a spectrum of viewpoints from ish to bearish.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.10300010000200001100062000In the assessment of 12-month price targets analysts unveil insights for Insmed presenting an average target of $99.0 a high estimate of $1
Mon May 12, 2025
Insmeds Q1 Loss Wider Than Expected Sales Match Estimates. INSM posts wider-than-expected loss in the first quarter. It reiterates the 2025 sales outlook for Arikayce in the range of $405-$425 million.
Fri May 9, 2025
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today. Insmed (NASDAQ:) has outperformed the market over the past 5 years by 6.96% on an annualized basis producing an average annual return of 21.46%. Currently Insmed has a market capitalization of $11.88 billion.
Fri May 9, 2025
Insmed targets $405M-$425M ARIKAYCE revenue and prepares for brensocatib launch in 2025.
Thu May 8, 2025
Insmed reports mixed Q1 results. reaffirms FY25 outlook.
Thu May 8, 2025
Earnings Scheduled For May 8 2025. . Sempra (NYSE:) is likely to report quarterly earnings at $1.32 per share on revenue of $3.92 billion. . Warner Music Gr (NASDAQ:) is projected to report quarterly earnings at $0.28 per share on revenue of $1.52 billion. . Cheniere Energy (NYSE:) is estimated to report quarterly earnings at $3.19 per share on revenue of $4.95 billion. . Royalty Pharma (NASDAQ:) is likely to report quarterly earnings at $0.95 per share on revenue of $724.69 million. . Insmed (N
Thu May 8, 2025
Insmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy.
Sun May 4, 2025
Is Insmed Gaining or Losing Market Support?. ) short percent of float has risen 4.19% since its last report. The company recently reported that it has Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price ...
Thu May 1, 2025
Notable Thursday Option Activity: INSM UNH LQDA. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Insmed Inc (Symbol: INSM) where a total volume of 16779 contracts has been traded thus far today a contract volume which is representative of approximately 1.
Thu Apr 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
INSM Stock trends
INSM Stock performance
INSM Stock analysis
INSM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Login to display Insmed (INSM) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
